Norepinephrine‐mediated activation of ADRB2 signaling could stimulate IL‐6 expression in ovarian tumors, suggesting the potential of sympathetic nerves in regulating the tumor immune microenvironment through the ADRB2/IL‐6 signaling axis [137, 138, 139]. This evidence concerns the gene IL6 and ovarian neoplasm.